These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 30515678)

  • 1. Use of antiosteoporotic drugs and calcium/vitamin D in patients with fragility fractures: impact on re-fracture and mortality risk.
    Degli Esposti L; Girardi A; Saragoni S; Sella S; Andretta M; Rossini M; Giannini S;
    Endocrine; 2019 May; 64(2):367-377. PubMed ID: 30515678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining the Effect of Medication Adherence on Risk of Subsequent Fracture Among Women with a Fragility Fracture in the U.S. Medicare Population.
    Keshishian A; Boytsov N; Burge R; Krohn K; Lombard L; Zhang X; Xie L; Baser O
    J Manag Care Spec Pharm; 2017 Nov; 23(11):1178-1190. PubMed ID: 29083977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Osteoporosis Medications Associated with Decreased Mortality after Hip Fracture.
    Wang PW; Li YZ; Zhuang HF; Yu HM; Cai SQ; Xu H; Chen ZH; Lin JK; Yao XD
    Orthop Surg; 2019 Oct; 11(5):777-783. PubMed ID: 31429532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-fracture prescribed calcium and vitamin D supplements alone or, in females, with concomitant anti-osteoporotic drugs is associated with lower mortality in elderly hip fracture patients: a prospective analysis.
    Nurmi-Lüthje I; Lüthje P; Kaukonen JP; Kataja M; Kuurne S; Naboulsi H; Karjalainen K
    Drugs Aging; 2009; 26(5):409-21. PubMed ID: 19552493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orthopedic-Metabolic Collaborative Management for Osteoporotic Hip Fracture.
    Rotman-Pikielny P; Frankel M; Lebanon OT; Yaacobi E; Tamar M; Netzer D; Nabriski D; Nyska M; Brin YS
    Endocr Pract; 2018 Aug; 24(8):718-725. PubMed ID: 30084682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoporotic fracture rate among women with at least 1 year of adherence to osteoporosis treatment.
    Modi A; Tang J; Sen S; Díez-Pérez A
    Curr Med Res Opin; 2015 Apr; 31(4):767-77. PubMed ID: 25708648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-hip fracture use of prescribed calcium plus vitamin D or vitamin D supplements and antiosteoporotic drugs is associated with lower mortality: a nationwide study in Finland.
    Nurmi-Lüthje I; Sund R; Juntunen M; Lüthje P
    J Bone Miner Res; 2011 Aug; 26(8):1845-53. PubMed ID: 21351147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing osteoporosis in ulcerative colitis: something new?
    Piodi LP; Poloni A; Ulivieri FM
    World J Gastroenterol; 2014 Oct; 20(39):14087-98. PubMed ID: 25339798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fracture prevention service to bridge the osteoporosis care gap.
    Ruggiero C; Zampi E; Rinonapoli G; Baroni M; Serra R; Zengarini E; Baglioni G; Duranti G; Ercolani S; Conti F; Caraffa A; Mecocci P; Brandi ML
    Clin Interv Aging; 2015; 10():1035-42. PubMed ID: 26150707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interdisciplinary fracture liaison service improves health-related outcomes and survival of older adults after hip fracture surgical repair.
    Ruggiero C; Baroni M; Talesa GR; Cirimbilli A; Prenni V; Bubba V; Parretti L; Bogini R; Duranti G; Caraffa A; Boccardi V; Mecocci P; Rinonapoli G
    Arch Osteoporos; 2022 Oct; 17(1):135. PubMed ID: 36251126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of bone protection and associated fragility injuries in patients with proximal femur fractures.
    Aguado-Maestro I; Panteli M; García-Alonso M; Bañuelos-Díaz A; Giannoudis PV
    Injury; 2017 Dec; 48 Suppl 7():S27-S33. PubMed ID: 28851521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of calcium supplements, vitamin D supplements and specific osteoporosis drugs among French women aged 75-85 years: patterns of use and associated factors.
    Castro-Lionard K; Dargent-Molina P; Fermanian C; Gonthier R; Cassou B
    Drugs Aging; 2013 Dec; 30(12):1029-38. PubMed ID: 24114665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Declining rates of osteoporosis management following fragility fractures in the U.S., 2000 through 2009.
    Balasubramanian A; Tosi LL; Lane JM; Dirschl DR; Ho PR; O'Malley CD
    J Bone Joint Surg Am; 2014 Apr; 96(7):e52. PubMed ID: 24695929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoporosis in the Women's Health Initiative: Another Treatment Gap?
    Sattari M; Cauley JA; Garvan C; Johnson KC; LaMonte MJ; Li W; Limacher M; Manini T; Sarto GE; Sullivan SD; Wactawski-Wende J; Beyth RJ
    Am J Med; 2017 Aug; 130(8):937-948. PubMed ID: 28366425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence and compliance to osteoporosis therapy in a fracture liaison service: a prospective cohort study.
    Senay A; Fernandes JC; Delisle J; Morin SN; Perreault S
    Arch Osteoporos; 2019 Aug; 14(1):87. PubMed ID: 31375983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers to secondary fracture prevention in primary care.
    Mendis AS; Ganda K; Seibel MJ
    Osteoporos Int; 2017 Oct; 28(10):2913-2919. PubMed ID: 28664275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation.
    Weaver CM; Alexander DD; Boushey CJ; Dawson-Hughes B; Lappe JM; LeBoff MS; Liu S; Looker AC; Wallace TC; Wang DD
    Osteoporos Int; 2016 Jan; 27(1):367-76. PubMed ID: 26510847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of osteoporotic treatment on the functional outcome, re-fracture rate, quality of life and mortality in patients with hip fractures: a prospective functional and clinical outcome study on 520 patients.
    Makridis KG; Karachalios T; Kontogeorgakos VA; Badras LS; Malizos KN
    Injury; 2015 Feb; 46(2):378-83. PubMed ID: 25541417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Application of guidelines for secondary prevention of fracture and the FRAX index in patients with fragility fracture].
    Naranjo A; Ojeda-Bruno S; Francisco-Hernández F; Erausquin C; Rúa-Figueroa I; Rodríguez-Lozano C
    Med Clin (Barc); 2011 Mar; 136(7):290-2. PubMed ID: 21185575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of missed opportunities for secondary fracture prevention in a regional general hospital setting in Singapore.
    Gani L; Reddy SK; Alsuwaigh R; Khoo J; King TFJ
    Arch Osteoporos; 2017 Dec; 12(1):60. PubMed ID: 28656564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.